TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34332154

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34332289

Group type: EXPERIMENTAL
Intervention: Online expressive writing intervention
Number of subjects: 63
Study: 34332522

Group type: EXPERIMENTAL
Intervention: Participation in the registry and management of in-hospital pediatric cardiac arrest.
Number of subjects: 0
Study: 34332533

Group type: EXPERIMENTAL
Intervention: Microbiome analysis using 3rd generation sequencing (Oxford Nanopore Technologies) for 16S rRNA and metagenomic sequencing.
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Microbiome sequencing as a predictor of severity and course of acute pancreatitis.
Number of subjects: 400
Study: 34332551

Group type: EXPERIMENTAL
Intervention: HIV-positive patients with ART
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: HIV-positive patients without ART
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: HIV-negative patients with COVID-19
Number of subjects: 1026
Study: 34332558

Group type: EXPERIMENTAL
Intervention: SGLT-2i
Number of subjects: 440599
Study: 34332614

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy (RCT)
Number of subjects: 32
Study: 34332620

Group type: EXPERIMENTAL
Intervention: Bedside lower limb angiography combined with continuous NIRS monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34332876

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus (DM)
Number of subjects: 5764

Group type: EXPERIMENTAL
Intervention: Elevated hemoglobin A1c (HbA1c)
Number of subjects: 5764

Group type: COMPARATOR
Intervention: Control group (non-DM)
Number of subjects: 5764
Study: 34332992

Group type: EXPERIMENTAL
Intervention: Cap-based adjuvant chemotherapy
Number of subjects: 21
Study: 34333320

Group type: EXPERIMENTAL
Intervention: Bullying experiences (cyber, verbal-relational, physical) among adolescents with obesity
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Verbal-relational bullying experiences
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Physical bullying experiences
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Cyberbullying experiences
Number of subjects: 328
Study: 34333554

Group type: EXPERIMENTAL
Intervention: Lutetium-177 treatment
Number of subjects: 40
Study: 34333603

Group type: EXPERIMENTAL
Intervention: Cushing syndrome patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control individuals
Number of subjects: 50
Study: 34334250

Group type: EXPERIMENTAL
Intervention: p75 neurotrophin receptor intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34334262

Group type: EXPERIMENTAL
Intervention: Structured online training programme
Number of subjects: 245
Study: 34334342

Group type: EXPERIMENTAL
Intervention: InterStim implant (de novo group)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: InterStim implant (replacement group)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: InterStim implant
Number of subjects: 291
Study: 34334709

Group type: EXPERIMENTAL
Intervention: Self-reported wheat sensitivity (SRWS)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Not-SRWS (Control)
Number of subjects: 496
Study: 34334713

Group type: EXPERIMENTAL
Intervention: Intravenous ustekinumab
Number of subjects: 31
Study: 34335213

Group type: EXPERIMENTAL
Intervention: Computer game-based rehabilitation treadmill platform (GRP) for dual-task (DT) assessment and training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single task (ST) condition
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dual-task (DT) condition
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PD-3 group
Number of subjects: 30

Group type: COMPARATOR
Intervention: PD-2 group
Number of subjects: 30
Study: 34335219

Group type: EXPERIMENTAL
Intervention: Surface electromyography based clinical assessment
Number of subjects: 0
Study: 34335289

Group type: EXPERIMENTAL
Intervention: Power training session
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34335296

Group type: EXPERIMENTAL
Intervention: CDP > 27.9
Number of subjects: 55

Group type: COMPARATOR
Intervention: FFR < 0.75
Number of subjects: 55
Study: 34335336

Group type: EXPERIMENTAL
Intervention: Web-based intervention to promote positive mental health, details on dosage and duration not available.
Number of subjects: 0
Study: 34335465

Group type: EXPERIMENTAL
Intervention: Low-dose relacorilant (100-200 mg/d) for 12 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-dose relacorilant (250-400 mg/d) for 16 weeks
Number of subjects: 34
Study: 34335479

Group type: EXPERIMENTAL
Intervention: Machine learning clustering based on AUCs of glucose and insulin during OGTT, and uric acid.
Number of subjects: 2495

Group type: EXPERIMENTAL
Intervention: Hypermetabolic obesity-hyperuricemia (HMO-U)
Number of subjects: 2495

Group type: EXPERIMENTAL
Intervention: Hypermetabolic obesity-hyperinsulinemia (HMO-I)
Number of subjects: 2495

Group type: EXPERIMENTAL
Intervention: Hypometabolic obesity (LMO)
Number of subjects: 2495

Group type: EXPERIMENTAL
Intervention: Machine learning clustering
Number of subjects: 2495
Study: 34335606

Group type: EXPERIMENTAL
Intervention: ChAd63/MVA Pfs25-IMX313
Number of subjects: 0
Study: 34336750

Group type: EXPERIMENTAL
Intervention: Social marketing intervention to engage older adults in balance workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34336760

Group type: EXPERIMENTAL
Intervention: Patient-centered care and gentle approach to treatment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Communication barriers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Systemic barriers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Good practice models
Number of subjects: 18
Study: 34337153

Group type: EXPERIMENTAL
Intervention: Online self-management intervention
Number of subjects: 267
Study: 34337278

Group type: EXPERIMENTAL
Intervention: Glucagon 12.5 ng/kg/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucagon 25 ng/kg/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 34337406

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy Diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34337481

Group type: EXPERIMENTAL
Intervention: Salvage magnetic resonance imaging-guided transurethral ultrasound ablation (sTULSA)
Number of subjects: 11
Study: 34337553

Group type: EXPERIMENTAL
Intervention: COVIDProtocols.org platform for developing and disseminating clinical guidelines
Number of subjects: 500000

Group type: EXPERIMENTAL
Intervention: Collaborative Writing Application (CWA)
Number of subjects: 500000

Group type: EXPERIMENTAL
Intervention: Web platform for content deployment
Number of subjects: 500000
Study: 34337556

Group type: EXPERIMENTAL
Intervention: RH5 antibodies from human vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34337972

Group type: EXPERIMENTAL
Intervention: Epigenetic factors associated with gestational diabetes and macrosomia
Number of subjects: 0
Study: 34338759

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Single antiplatelet therapy (SAPT)
Number of subjects: 199
Study: 34338965

Group type: EXPERIMENTAL
Intervention: Palbociclib plus Letrozole (PAL+LET)
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Letrozole (LET)
Number of subjects: 1383

Group type: EXPERIMENTAL
Intervention: Palbociclib plus Letrozole (PAL+LET) after propensity-score matching
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Letrozole (LET) after propensity-score matching
Number of subjects: 1383
Study: 34339017

Group type: EXPERIMENTAL
Intervention: Proactive management (PM) using calcipotriene 0.005%/betamethasone dipropionate 0.064% foam, twice-weekly during maintenance phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive management (RM) using vehicle foam
Number of subjects: 0
Study: 34339261

Group type: EXPERIMENTAL
Intervention: Amivantamab
Number of subjects: 0
Study: 34339292

Group type: EXPERIMENTAL
Intervention: Amivantamab
Number of subjects: 81
Study: 34340209

Group type: EXPERIMENTAL
Intervention: Parallel tumor-normal genetic testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tumor-only testing
Number of subjects: 0
Study: 34340523

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34340693

Group type: EXPERIMENTAL
Intervention: Internet-based recruitment via social media
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Follow-up survey participation
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Retention rates
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Overall trial implementation
Number of subjects: 1971
Study: 34341101

Group type: EXPERIMENTAL
Intervention: Edinburgh Postnatal Depression Scale (EPDS) at NICU admission, discharge, 14 days and 30 days postdischarge
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Screening for postpartum depression during NICU stay
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Focused attention on fathers
Number of subjects: 431
Study: 34341142

Group type: EXPERIMENTAL
Intervention: anti-CD20 therapies
Number of subjects: 119

Group type: COMPARATOR
Intervention: DMTs other than anti-CD20
Number of subjects: 119

Group type: COMPARATOR
Intervention: No DMT
Number of subjects: 119
Study: 34341335

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine (two doses)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: AZD1222 vaccine (one dose)
Number of subjects: 276

Group type: COMPARATOR
Intervention: MM patients
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Active treatment with anti-CD38 monoclonal antibodies or belantamab mafodotin
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Lymphopenia at the time of vaccination
Number of subjects: 276
Study: 34342012

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baseline AI-BNST RSFC measurement
Number of subjects: 18
Study: 34342022

Group type: EXPERIMENTAL
Intervention: At-risk alcohol use (AUDIT score ≥ 5)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-risk alcohol use (AUDIT score < 5)
Number of subjects: 105
Study: 34342304

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34342499

Group type: COMPARATOR
Intervention: CAC score <1000
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: CAC score ≥1000
Number of subjects: 309
Study: 34342593

Group type: EXPERIMENTAL
Intervention: Telehealth intervention focusing on hypoglycemia education and symptom monitoring, including initial in-person visit, 3 weekly telecoaching calls, 1 biweekly call, and final in-person visit over 8 weeks.
Number of subjects: 40
Study: 34342746

Group type: EXPERIMENTAL
Intervention: Lurasidone (20-120 mg/day)
Number of subjects: 49
Study: 34342768

Group type: EXPERIMENTAL
Intervention: Saliva NAAT (three different protocols)
Number of subjects: 1452

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal Ag test
Number of subjects: 1452

Group type: COMPARATOR
Intervention: Nasopharyngeal NAAT
Number of subjects: 1452
Study: 34342846

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQoL) assessment using SF-6D
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pain Catastrophizing Scale (PCS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tampa Scale for Kinesiophobia (TSK)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pain Vigilance and Awareness Questionnaire (PVAQ)
Number of subjects: 120
Study: 34343107

Group type: EXPERIMENTAL
Intervention: ROCHE Elecsys® immunoassay
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: IMMULITE-2000 immunoassay
Number of subjects: 911

Group type: COMPARATOR
Intervention: Previous six immunoassays (iSYS, LIAISON XL, IMMULITE-2000 calibrated against IS 87/518, IGF-I RIACT, Mediagnost ELISA, Mediagnost RIA)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: All eight IGF-I assays
Number of subjects: 911
Study: 34343142

Group type: EXPERIMENTAL
Intervention: Central blood pressure measurement using SphygmoCor System
Number of subjects: 501

Group type: COMPARATOR
Intervention: Hypertension status
Number of subjects: 501

Group type: COMPARATOR
Intervention: Diabetes status
Number of subjects: 501

Group type: COMPARATOR
Intervention: Obesity status
Number of subjects: 501

Group type: COMPARATOR
Intervention: Smoking status
Number of subjects: 501
Study: 34343354

Group type: EXPERIMENTAL
Intervention: Tafasitamab 12 mg/kg weekly for up to four 28-day cycles
Number of subjects: 22
Study: 34343443

Group type: EXPERIMENTAL
Intervention: Maraviroc treatment
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: V3-loop CCR5-tropic sequences
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Univariate analysis of variants
Number of subjects: 704
Study: 34343712

Group type: EXPERIMENTAL
Intervention: Degradable polymer film (DPF) inserted after hysteroscopic transcervical myoma resection
Number of subjects: 23
Study: 34344169

Group type: EXPERIMENTAL
Intervention: Measured RMR using indirect calorimetry
Number of subjects: 92

Group type: COMPARATOR
Intervention: Predictive equations (Harris Benedict, Mifflin-St Jeor, WHO, Academy for Nutrition and Dietetics)
Number of subjects: 92
Study: 34344717

Group type: EXPERIMENTAL
Intervention: Driving pressure (ΔP) on the first day of mechanical ventilation
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1575
Study: 34344835

Group type: EXPERIMENTAL
Intervention: End-tidal partial pressure of CO
Number of subjects: 25
Study: 34344873

Group type: EXPERIMENTAL
Intervention: Radiolabeled epichaperome probe administered by intravenous injection (single microdose)
Number of subjects: 0
Study: 34345170

Group type: EXPERIMENTAL
Intervention: Chronic Bronchitis (CB)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Emphysema (EM)
Number of subjects: 420
Study: 34345718

Group type: EXPERIMENTAL
Intervention: Adaptation and validation of the CRAFFT screening tool for alcohol use
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Cross-sectional community household survey
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Urine samples collection for EtG measurement
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Surveys and qualitative assessments in health and school systems
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Qualitative interviews with children
Number of subjects: 3500
Study: 34346898

Group type: EXPERIMENTAL
Intervention: Immersive virtual shopping experience
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cognitive challenge condition
Number of subjects: 84

Group type: COMPARATOR
Intervention: Emotional challenge condition
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 84
Study: 34346900

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy delivered via a smartphone mHealth app
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 34347267

Group type: EXPERIMENTAL
Intervention: Mealtime URLi
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Postmeal URLi
Number of subjects: 167

Group type: COMPARATOR
Intervention: Mealtime lispro
Number of subjects: 167
Study: 34347504

Group type: EXPERIMENTAL
Intervention: New model for promoting widespread access to mental health care for depression and unhealthy alcohol use, utilizing mobile health technology.
Number of subjects: 0
Study: 34347542

Group type: EXPERIMENTAL
Intervention: Ribociclib with TOTEM (topotecan and temozolomide)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ribociclib with everolimus
Number of subjects: 32
Study: 34347859

Group type: EXPERIMENTAL
Intervention: LDL-C <70 mg/dL
Number of subjects: 42378

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 42378

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 42378

Group type: COMPARATOR
Intervention: Ticagrelor vs. Clopidogrel
Number of subjects: 42378
Study: 34347952

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 192

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 192
Study: 34348045

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34348230

Group type: EXPERIMENTAL
Intervention: PRIME (Peripheral Remodeling through Intermittent Muscular Exercise)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 75
Study: 34348472

Group type: EXPERIMENTAL
Intervention: Mobile Interventional Stroke Team (MIST)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Drip-and-ship (DS) model
Number of subjects: 226
Study: 34348660

Group type: EXPERIMENTAL
Intervention: New primary care model including frailty screening, online portal for referrals, and tools for patient engagement and shared decision-making.
Number of subjects: 1600000

Group type: COMPARATOR
Intervention: Usual care (baseline assessment).
Number of subjects: 1600000
Study: 34348724

Group type: EXPERIMENTAL
Intervention: Anticoagulant, antiaggregant, and anticoagulant plus antiaggregant drugs
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Diagnosis of lung neoplasm
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Diagnosis of bronchiectasis
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Recurrence of haemoptysis
Number of subjects: 451
Study: 34348797

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation exposure
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Spontaneous breathing for more than 14 days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-protective tidal volume
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Positive fluid balance
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High plasma D-dimers
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High ferritin levels
Number of subjects: 23
Study: 34348889

Group type: EXPERIMENTAL
Intervention: electronically delivered cognitive behavioral therapy (e-CBT) for OCD, 16-week program
Number of subjects: 5
Study: 34348918

Group type: EXPERIMENTAL
Intervention: ZnT8A testing using age-related cut-offs
Number of subjects: 1704

Group type: COMPARATOR
Intervention: Manufacturer's recommended threshold of 6 WHO U/mL
Number of subjects: 1704
Study: 34348942

Group type: EXPERIMENTAL
Intervention: Stepwise treatment algorithm based on BFI score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conventional laxatives
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Peripherally acting mu-opioid receptor antagonist (PAMORA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PAMORA and conventional laxative
Number of subjects: 100
Study: 34348950

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT) delivered in 10 sessions over 6 weeks with an accompanying home exercise programme (HEP)
Number of subjects: 24
Study: 34348965

Group type: EXPERIMENTAL
Intervention: Low glycaemic index/glycaemic load dietary patterns
Number of subjects: 1617
Study: 34349004

Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain (pNfL) levels in patients with genetic FTD/ALS
Number of subjects: 668

Group type: COMPARATOR
Intervention: Plasma neurofilament light chain (pNfL) levels in controls
Number of subjects: 668
Study: 34349026

Group type: EXPERIMENTAL
Intervention: CPL207280, a GPR40/FFA1 agonist; specific dosage and duration not mentioned
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group; specific details not mentioned
Number of subjects: 0
Study: 34349180

Group type: EXPERIMENTAL
Intervention: N-acetyl-D,L-leucine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-acetyl-L-leucine
Number of subjects: 0
Study: 34349563

Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic period (January 21 to July 31, 2020)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-COVID-19 period (same period in 2019)
Number of subjects: 0
Study: 34349716

Group type: EXPERIMENTAL
Intervention: Arm Ergometry intervention, details on dosage and duration not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group, details not available
Number of subjects: 0
Study: 34350144

Group type: EXPERIMENTAL
Intervention: Infant massage (IM) delivered by parents at home
Number of subjects: 0
Study: 34350300

Group type: EXPERIMENTAL
Intervention: Single-bundle (SB) ACLR
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Single-bundle plus lateral plasty (SBLP) ACLR
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ACLR (both techniques)
Number of subjects: 32
Study: 34350455

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin (hs-cTn) based algorithms in anaemic patients
Number of subjects: 2223

Group type: COMPARATOR
Intervention: High-sensitivity cardiac troponin (hs-cTn) based algorithms in non-anaemic patients
Number of subjects: 2223

Group type: EXPERIMENTAL
Intervention: Anaemia as a predictor
Number of subjects: 2223

Group type: EXPERIMENTAL
Intervention: Hb associated with hs-cTn
Number of subjects: 2223
Study: 34350521

Group type: EXPERIMENTAL
Intervention: SHUEE
Number of subjects: 20
Study: 34350582

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 7452
Study: 34350730

Group type: EXPERIMENTAL
Intervention: Eplerenone (mineralocorticoid blockade) for 8 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Healthy controls (n=10; male/female, Caucasians)
Number of subjects: 13
Study: 34350814

Group type: EXPERIMENTAL
Intervention: Multi-level intervention aimed at introducing more traditional AN subsistence foods, increasing fruit and vegetable intake, and decreasing sugar-sweetened beverage (SSB) consumption.
Number of subjects: 22
Study: 34350827

Group type: EXPERIMENTAL
Intervention: T-REX machine learning workflow
Number of subjects: 0
Study: 34350976

Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 2750
Study: 34351368

Group type: EXPERIMENTAL
Intervention: Less-intensive therapies
Number of subjects: 1987

Group type: COMPARATOR
Intervention: Intensive therapies
Number of subjects: 1987
Study: 34351679

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2-Positive Donor to a SARS-CoV-2-Positive Recipient
Number of subjects: 0
Study: 34351867

Group type: EXPERIMENTAL
Intervention: Health Check-Up for Expectant Moms (HCEM) intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: In-person recruitment
Number of subjects: 136